DDIS-35. RelA-ACTIVITY IS ESSENTIAL FOR CANNABIDIOL-MEDIATED CYTOTOXICITY IN AN IDENTIFIED SUBSET OF GLIOBLASTOMA

Glioblastoma (GBM) therapy could strongly profit from simplified procedures for personalized medicine. Cannabidiol (CBD) is explored for GBM-patients, but the mode of drug-action is largely unknown and stratification markers are missing. We investigated CBD-induced cytotoxicity in a panel of human p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Volmar, Marie, Nagl, Bernhard, Haug, Alisha, Richter, Sven, Alenezi, Haithanm, Herold-Mende, Christel, Lamszus, Katrin, Synowitz, Michael, Schick, Joel, Kälin, Roland, Glass, Rainer
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Drug Discovery
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6846907/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.286
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados